BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23537713)

  • 1. Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.
    Zhang Y; Cook A; Kim J; Baranov SV; Jiang J; Smith K; Cormier K; Bennett E; Browser RP; Day AL; Carlisle DL; Ferrante RJ; Wang X; Friedlander RM
    Neurobiol Dis; 2013 Jul; 55():26-35. PubMed ID: 23537713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.
    Rao MV; Campbell J; Palaniappan A; Kumar A; Nixon RA
    J Neurochem; 2016 Apr; 137(2):253-65. PubMed ID: 26756888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model.
    Li W; Fotinos A; Wu Q; Chen Y; Zhu Y; Baranov S; Tu Y; Zhou EW; Sinha B; Kristal BS; Wang X
    Neurobiol Dis; 2015 Aug; 80():93-103. PubMed ID: 25986728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
    J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS.
    Koh SH; Kim Y; Kim HY; Hwang S; Lee CH; Kim SH
    Exp Neurol; 2007 Jun; 205(2):336-46. PubMed ID: 17433298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis.
    Miquel E; Cassina A; Martínez-Palma L; Bolatto C; Trías E; Gandelman M; Radi R; Barbeito L; Cassina P
    PLoS One; 2012; 7(4):e34776. PubMed ID: 22509356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity.
    Wang X; Sirianni A; Pei Z; Cormier K; Smith K; Jiang J; Zhou S; Wang H; Zhao R; Yano H; Kim JE; Li W; Kristal BS; Ferrante RJ; Friedlander RM
    J Neurosci; 2011 Oct; 31(41):14496-507. PubMed ID: 21994366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis.
    Takata M; Tanaka H; Kimura M; Nagahara Y; Tanaka K; Kawasaki K; Seto M; Tsuruma K; Shimazawa M; Hara H
    Br J Pharmacol; 2013 Sep; 170(2):341-51. PubMed ID: 23763343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking hypoxic and oxidative insults to cell death mechanisms in models of ALS.
    Xu R; Wu C; Zhang X; Zhang Q; Yang Y; Yi J; Yang R; Tao Y
    Brain Res; 2011 Feb; 1372():133-44. PubMed ID: 21111718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1-G93A mouse model.
    Zhang JJ; Zhou QM; Chen S; Le WD
    CNS Neurosci Ther; 2018 Dec; 24(12):1163-1174. PubMed ID: 29656576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
    Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.